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This article provides a succinct but limited overview of the protective and deleterious effects of reactive
oxygen and nitrogen species in a clinical context. Reactive oxygen species include superoxide, hydrogen
peroxide, single oxygen and lipid peroxides. Reactive nitrogen species include species derived from
nitric oxide. This review gives a brief overview of the reaction chemistry of these species, the role of
various enzymes involved in the generation and detoxiﬁcation of these species in disease mechanisms
and drug toxicity and the protective role of dietary antioxidants. I hope that the graphical review will be
helpful for teaching both the ﬁrst year medical and graduate students in the U.S. and abroad the
fundamentals of reactive oxygen and nitrogen species in redox biology and clinical medicine.
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the Fall semester of 2012 at the Medical College of Wisconsin. I was
asked by Dr. Nancy Dahms, the course director of M1 Biochemistry,
to present a lecture on the medical relevance of active oxygen and
oxidative stress. In the past, this lecture was taught by Dr. Owen
Grifﬁth. When I was asked to ﬁll in his shoes (as if anyone could), I
felt it was a great honor. I was also inspired by Dr. Barry Halliwell
for emphasizing the importance of teaching free radical science to
medical students [1]. I hope that this chapter will provide an
increased awareness as to why understanding the basics of free
radicals in disease mechanisms is so vital for providing better
treatment and enhanced quality of life in clinical patients.Introduction to reactive oxygen and nitrogen species
(ROS/RNS)
A free radical is an atom or molecule with a single unpaired
electron. Examples: Nitric oxide (NO), superoxide (O2–), hydroxyl
radical (OH), lipid peroxy radical (LOO). Althoughmolecular oxygen
(O2) has two unpaired electrons in two different orbitals, it is not a
free radical. Molecular oxygen, however, reacts rapidly with mostLight, dye
Fig. 2. Molecular orbital representatio
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Fig. 1. Sequential reduction of O2 to H2O.other radicals, forming other free radicals that are more reactive and
cause selective oxidation of lipid, protein, or DNA molecules [2].
Oxygen, or molecular oxygen, is vital for survival of all aerobic
organisms. During aerobic metabolism in normal cells, 30–32
molecules of adenosine triphosphate (ATP) are generated from
one molecule of oxygen. During this process, oxygen is reduced
into water (4 electron reduction) (Fig. 1). Oxygen is an essential
co-factor in many biological oxidations and drug metabolism
catalyzed by monoxygenases or mixed function oxidases
(cytochrome P450).
In a perfect world, cells will use oxygen to produce ATP and
water without any toxic byproducts or activated (also active) oxygen
species. However, damage to mitochondria in pathophysiological
conditions or during mitochondrial dysfunction, the electron-
transport mechanism in the mitochondrial respiratory chain is
impaired. This leads to reactive oxygen species formation (e.g.,
superoxide anion) from one-electron reduction of oxygen. Fig. 2
shows the molecular orbital diagrams of oxygen, superoxide, per-
oxide dianion, and the singlet oxygen. It is evident from the
molecular orbital representation that not all active oxygen species
is a free radical.
Superoxide is a free radical (species with a single electron) as is
hydroxyl radical. Hydrogen peroxide is not a free radical, but is a
precursor of free radicals. UV radiation causes the hemolytic
cleavage of the oxygen–oxygen bond to form hydroxyl radicals
(OH). Redox metal ions (Fe2þ or Fe3þ or Cuþ) react with hydrogen
peroxide to generate hydroxyl radicals (the Fenton reaction). Singlet
oxygen is not a free radical and is a photoexcited oxygen species. Inn of oxygen and active oxygens.
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proteins, and lipids), hydroxyl radical is the most reactive, and the
lifetime of this species in the presence of most biological constitu-
ents is extremely short (10–9 s). There is no selectivity for hydroxyl
radical reactions—this species will react with most compounds at a
nearly diffusion-controlled rate (1010 M–1 s–1).
Some antitumor drugs (e.g., doxorubicin) exert toxic side effects
in cardiac myocytes through this mechanism [3]. One way to
counteract the toxic side effect of this chemotherapeutic is through
iron chelating molecules that tie up the iron ions and inhibit
formation of hydroxyl radicals. Superoxide is much less reactive
and much more selective. Its lifetime in biological systems is a few
seconds. Superoxide rapidly reacts with another molecule of
superoxide (self-dismutation reaction) to form hydrogen peroxide.
Another important reaction in biology is the diffusion-controlled
reaction between superoxide with nitric oxide (radical–radical
reaction) to form a very potent oxidant and reactive nitrogen
species, peroxynitrite (half-life, seconds) [4]. Hydrogen peroxide
(H2O2) is relatively stable (half-life, months) when protected
against light and trace metal contamination. H2O2 is, however,
rapidly destroyed by antioxidant enzymes (catalase, glutathione
peroxidase). Singlet oxygen reacts rapidly with histidine and
cysteinyl groups present in proteins, unsaturated lipids and some
nucleic acids [2]. Typically this species has a half-life of around
10 ms. Another immunologically relevant reactive oxygen species is
hypochlorous acid (HOCl, or bleach). HOCl is formed from myelo-
peroxidase/H2O2-dependent oxidation of chloride anion. HOCl has
intermediate reactivity-more reactive than H2O2 but considerably
less reactive than hydroxyl radicals. Fig. 3 summarizes the reac-
tions initiated by reactive oxygen and nitrogen species.
In contrast to normal cells, cancer cells avoid using the aerobic
metabolism to produce ATP, and they utilize a rather inefﬁcient
pathway (anerobic glycolysis) to generate 2 molecules of ATP.
Cancer cells are metabolically reprogrammed to make the switch
from oxidative phosphorylation to glycolysis. Cancer cells are also
hypoxic (less oxygen), which makes it harder to kill tumor cells
more effectively during radiation and chemotherapy, that are
based on selective generation of damaging reactive oxygen species.
Some of the newer antitumor compounds force the cancer cells toFig. 3. Reactive oxygen and nitrogen species: generation and reactions.use mitochondrial oxidative phosphorylation pathway to derive its
source of energy (ATP). However, the mechanisms underlying this
cytotoxic switch in cancer cells are not very clear.Superoxide (the good side): respiratory burst or oxidative burst
Phagocytes (neutrophils, monocytes, eosinophils) kill invading
pathogens and defend the host through generation of antimicrobial
oxidants such as O2
– or O2–-derived oxidants during the respira-
tory burst or enhanced oxygen consumption. Note: The respiratory
burst can also be stimulated by opsonized microorganism (opsonized
zymosan) and chemicals such as phorbol myristate acetate (PMA).
Although O2
– itself is only weakly microbicidal, oxidants generated
from O2
– are strongly microbicidal. The enzyme responsible for O2–
generation was shown to be a membrane-bound ﬂavoprotein or
the NADPH oxidase that uses NADPH as a co-factor. This enzyme is
the cells come in contact with bacteria and other appropriate
stimulus. As discussed earlier, the active NADPH oxidase assembly
comprises of multiple cytosolic and plasma membrane compo-
nents and catalyzes the one-electron reduction of oxygen to
superoxide at the expense of NADPH [5].
The schematic illustration of the phagocytic process is shown
in Fig. 4. The phagocyte ﬁnds a bacteria marked as foreign (i.e.,
coated by the complement or immune system) [2]. The phagocyte
plasma membrane surrounds the bacteria and engulfs the
microprobe into a phagocytic vacuole. Enzymes (NADPH oxidase)
are selectively activated in the wall of vacuole, generating O2
– and
H2O2 in the vacuolar lumen. Activation of NADPH oxidase
requires translocation of several key cytosolic proteins (p44phox,
p67phox, p40phox, and rac2) to the membrane. Although O2
–
production is essential for bacterial cell killing, O2
– alone is not
responsible for bacterial killing. H2O2 in the presence of released
iron could form hydroxyl radical, a potent oxidant, via the Fenton
mechanism (Fe2þþH2O2-Fe3þþOHþOH) or the Haber–
Weiss mechanism (O2 þH2O2!Fe
3þ OHþOHþO2). Hydroxyl
radical is a potent antimicrobial oxidant [6].
The enzyme, myeloperoxidase (MPO), is released inside the
phagocytic vacuole from granules and comprises 2–5% of total
neutrophil protein. MPO is a heme-containing peroxidase that
will oxidize halide anion (chloride, bromide, and iodide anions) in
the presence of H2O2, forming the corresponding hypohalous acid.
In the case of chloride anion, hypochlorous acid (HOCl) or Clorox
(bleach) is formed. HOCl kills many bacteria and fungi in vitro.
HOCl is very reactive and causes oxidation and chlorination of
biological molecules. Although HOCl plays a role in bacterialDegranulation
NADP+
NADPH
oxidase −
NADPH
O2
MPO
HOCl (Clorox)
O2• → H2O2
_
Cl−
Phagocyte 
vacuole
Bacteria
Fig. 4. Schematic representation of a phagocyte engulﬁng a microbe into a phagocyte
vacuole. The NADPH oxidase is selectively activated in the wall of the vacuole,
generating superoxide and hydrogen peroxide in the vacuolar lumen. Enzymes are
also released into the vacuole by degranulation of cytoplasmic granules.
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– is more important than MPO in the
overall bacterial killing during respiratory burst [7].
Chronic granulomatous disease (CGD) is a rare genetic disease
of the immune system and is an inherited deﬁciency of NADPH
oxidase [8]. CGD is caused by defects in one of the ﬁve subunits of
phagocyte-derived NADPH oxidase including gp91phox, p22phox,
p47phox, p67phox, and p40phox. Consequently, the NADPH oxidase is
not fully functional in CGD patients, and the production of super-
oxide and other reactive intermediates is impaired in their phago-
cytic cells, leading to infections and other complications [2].
Neutrophils isolated from blood from CGD patients generate less
O2
– and oxidative respiratory burst compared to healthy indivi-
duals. Neutrophil-derived O2
– and reactive oxidant formation may
be used as a diagnostic indicator of the severity of the disease, and
a strong predictor of the overall survival of CGD patients. Phago-
cytes of CGD patients lack the antimicrobial arsenal needed to
‘‘kill’’ the engulfed bacteria. CGD patients do not make sufﬁcient
O2
– and H2O2. As H2O2 is the substrate for the enzyme myeloper-
oxidase, neutrophils from CGD patients do not make hypochlorous
acid or the bleach, a commonly used antibacterial agent.Reperfusion injury—clinical implications (the bad side of O2
–)
Ischemia (or deprivation of oxygen) and regional ischemic
episodes occur in several clinical situations due to severe restric-
tions in blood ﬂow; for example, in heart tissues during myocardial
infarction or in brain tissues during stroke. Clearly, the appropriate
medical intervention is to restore oxygen immediately to tissues by
removing the blockage in the artery (by administering clot dissol-
ving drugs, tissue plasminogen activator (TPA), or use of balloon
catheters). Although this treatment is mostly beneﬁcial, resump-
tion of blood ﬂow (reoxygenation or reperfusion) in ischemic
tissues has been shown to cause tissue damage or reperfusion
injury, depending on the ischemic duration. This phenomenon is
known as the ‘‘oxygen paradox’’. It was proposed that reperfusion-
derived free radicals were responsible for postischemic tissue
injury [9]. The proposed biochemical mechanism for enhanced
generation of superoxide during reperfusion is shown in Fig. 5.
Two major changes occur in ischemic or oxygen-deprived tissues:
ﬁrst, ischemic conditions promote the conversion of xanthine dehy-
drogenase (XD) to xanthine oxidase (XO). The enzyme XD is unable to
transfer electrons to molecular oxygen, although it uses NADPH as an
electron acceptor. The conversion of XD to XO involves either the
oxidation of the sulfhydryl group or proteolysis triggered by the
activation of a cytosolic protease as an adaptive mechanism for
calcium transport in energy-starved cells. The molecule calmodulin
also plays a role in proteolytic activation. The second major biochem-
ical change that occurs in ischemic tissues is depletion of ATP to AMP,ATP
adenosine
AMP xanthine 
dehydroxygenase
inosine xanthine 
Ca++ proteaseis
ch
em
ic
hypoxanthine
oxidase
O2   , H2O2,  OH
_
• •
O2
reoxygenation
Fig. 5. Proposed mechanism for ischemia-induced formation of reactive oxygen
species. [Modiﬁed from: McCord, J. M. Oxygen-derived free radicals in postis-
chemic tissue injury. New England Journal of Medicine 312:159–163; 1985.]catabolism of AMP, and eventually accumulation of hypoxanthine, a
purine substrate for the enzyme XO. Actually the buildup of hypox-
anthine has been demonstrated in ischemic myocardium. As indi-
cated earlier, the XO activity converts xanthine or hypoxanthine to
uric acid, and molecular oxygen to superoxide and hydrogen per-
oxide. Ischemic conditions also promote the release of redox-active
metals (e.g., iron) that can enable more potent oxidant (hydroxyl
radical via the Fenton mechanism) formation. Thus, the biochemical
machinery is ripe for increased oxygen-derived radical formation
under ischemic conditions, and is facilitated by reperfusion that
provides the remaining substrate, molecular oxygen [10].
Increased formation of oxygen-derived radicals is one of the
factors of reperfusion-induced injury in many ischemic diseases
of the heart, kidney, brain, liver, bowel, and in organ transplanta-
tion [10]. One way to protect against reperfusion-induced tissue
damage is to use enzymatic scavengers of superoxide and hydro-
gen peroxide (SOD and CAT), iron chelators (deferoxamine), and
inhibitors of the enzyme, XO (allopurinol, oxypurinol) [9].Organ preservation and transplantation
Reperfusion injury is a potential complicating factor in the
transplant surgery. Typically, once a donated organ (e.g., kidney)
is removed from a cadaver, packed in ice, and maintained at low
temperature in a preservation liquid, then transplanted and
reperfused in the recipient, the transplanted organ can suffer
oxygen radical-mediated reperfusion injury. This can lead to
organ necrosis and organ failure. In preclinical studies, it has
been shown that pretreatment with allopurinol or antioxidant
enzymes improves organ function and graft survival [9].The University of Wisconsin (UW) solution/Carolina rinse solution:
strategies in mitigating storage/reperfusion injury
Not all cells are equally affected during storage/reperfusion
process. For example, hepatocytes are very resistant to storage/
reperfusion injury, even after many hours of cold hypoxia/anoxia.
Multiple mechanisms and multiple cell types contribute to storage/
reperfusion injury. The UW solution, introduced in the 1980s, is
being used as a gold standard for organ preservation [11]. This
solution contains multiple components: antioxidants (glutathione,
alpha-tocopherol, ascorbic acid), apllopurinol, ATP precursors,
amino acids, bioenergetics precursors and electrolytes.
In many respects, the Carolina rinse solution is similar in
composition to the UW solution. This solution has been mostly
used to mitigate storage/reperfusion injury to the liver. Different
cells (endothelial cells and Kupffer cells) play a role in reperfusion
injury after prolonged liver storage (Fig. 6).
Activated Kupffer cells, upon reperfusion, release NO, O2–, and
ONOO , in addition to other inﬂammatory mediators (cytokines).
Clearly, antioxidant strategies to improve organ preservation,Fig. 6. Reperfusion injury to liver cells. [Modiﬁed from: Lemasters, J. L.; Thurman,
R.G. Reperfusion injury after liver preservation for transplantation. Annual Review
of Pharmacology and Toxicology 37:327–338; 1997.].
B. Kalyanaraman / Redox Biology 1 (2013) 244–257248graft survival, and organ function are a fruitful area of research
investigation.
Singlet oxygen (the good side)
The singlet oxygen or the electronically excited oxygen differs
frommolecular oxygen in its electronic conﬁguration. Whereas the
oxygen that we breathe is in the triplet state with two unpaired
electrons and is relatively unreactive with biological components,
the singlet oxygen has no unpaired electron and both electrons
occupy the same molecular orbital, leaving an empty orbital for
reaction with other molecules. In contrast to molecular oxygen, the
singlet oxygen reacts rapidly with most biological constituents and
causes oxidative damage (e.g., conversion of an unsaturated lipid
molecule to a lipid peroxide molecule) [2].
The singlet oxygen is formed from illuminating a photosensitiz-
ing dye (S) with visible light in the presence of oxygen [12]. The
photosensitizing dye (e.g., Photofrin or merocyanine 540) absorbs
the light energy in the visible region and activates the dye to form
the excited singlet state (reaction 1) which undergoes intersystem
crossing (IC) to the relatively long-lived triplet state dye (reaction 2),
as shown below. The triplet state dye molecule interacts with
molecular oxygen (transfers the excess energy to molecular oxygen),
forming the singlet oxygen (reaction 3) which immediately reacts
with the cellular target (membrane or protein) and causes oxidative
damage (Fig. 7).
Photodynamic therapy (PDT)
PDT refers to the selective destruction of tumor c ells in the
presence of a sensitizer (usually a dye molecule), visible light, and
oxygen [12]. Selective cytotoxicity to tumor cells originates from
selective binding to tumor cell membrane and accumulation/
retention of the dye in tumor cells and/or from a localized light
delivery and irradiation of tumor cells leading to singlet oxygen
generation in tumor tissues. PDT is an anticancer therapy that
results in localized tissue destruction due to focused light deliveryS
light
(1)1S
S 3S (2)1
3S + 
3O2
IC
(3) (Type 1O2 + S
(4)1O2 + Target                       Target(oxidized)
(Target=unsaturated phospholipid,
histidine, and protein sulfydryls)
Fig. 7. Dye-sensitized phot
Fig. 8. Sildenaﬁl-induced smooand laser light. In one of the landmark clinical studies, investiga-
tors showed successful ablation of Barrett’s esophagus with
high-grade dysplasia using PDT [13].Selective purging of cancer cells from bone marrow
Researchers at MCW discovered a novel PDT-based approach
to selectively purge leukemic cells from bone marrow [14]. PDT
was performed using a ﬂuorescent dye, merocyanine 540
(MC540). MC540 selectively binds to the outer surface of the
plasma membrane of leukemic cells which is responsible for the
differential sensitivity of normal and neoplastic cells to MC540/
PDT [14]. Simultaneous exposure to MC540 and visible light
rapidly killed leukemic cells but spared the normal cells. Basic
mechanistic studies revealed that singlet oxygen plays a major
role in the MC540-mediated photodynamic killing of leukemic
cells. MCW researchers were also involved in the MC540/PDT
therapy (phase 1/11 clinical trials) for the purging of autologous
bone marrow transplants in leukemia and lymphoma patients.Singlet oxygen phototoxicity (the bad side)
Increased photosensitivity of the skin is the most common form
of adverse side effects. The photosensitizing dye typically remains
in the skin at low levels for a long period of time. Patients with
photosensitive skin should be protected from sunlight for several
months after treatment. The deleterious effects to normal cells
during PDT result from singlet oxygen-mediated damaging effects.
Several disorders can result in excessive formation of singlet
oxygen in the presence of light, including porphyria (defective
heme biosynthesis). In cutaneous porphyrias, porphyrins accu-
mulate in the skin. Exposure to light causes skin blistering and
swelling mediated by singlet oxygen formation. Several anti-
inﬂammatory drugs (e.g., benoxaprofen) have been discontinued
due to potential phototoxicity arising from light-induced singlet
oxygen formation.11 mechanism)
Merocyanine 540 (MC540)
oactivation of oxygen.
th muscle cell relaxation.
Fig. 9. Enzymatic generation of NO from L-arginine.
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Depending upon their concentrations, not all free radicals
are damaging and bad. For instance, NO, a free radical gas, is an
important intracellular messenger molecule that activates the soluble
guanylyl cyclase (sGC) at nanomolar concentrations. Guanylyl cyclase
is responsible for converting guanosine triphosphate (GTP) to cyclic
GMP, which causes smooth muscle relaxation [15].
Prior to 1980, NO, which is present in automobile exhaust and
cigarette smoke, was largely considered as an environmental
pollutant. This view of NO changed in the 1980s when Robert
Furchgott discovered that the endothelium released a labile factor,
termed ‘‘endothelial-derived relaxing factor’’ (EDRF), which caused
vascular relaxation when vascular smooth muscle cell preparations
were stimulated with vasodilators (e.g., acetylcholine, histamine,
and bradykinin) [16]. EDRF was also called ‘‘nitrovasodilator’’
because nitrovasodilators such as nitroglycerin, nitroprusside,
other organic nitrites, cause vascular relaxation [17]. Subsequently,
it was proposed that EDRF is NO. For this discovery, a group of
investigators (Ignarro, Furchgott, and Murad) received the Nobel
Prize in Physiology/Medicine in 1998.
Clinical signiﬁcance of NO and cGMP signaling
Male impotence is a major, worldwide clinical problem.
Abnormal vascular responsiveness leading to impaired relaxation
of the smooth muscle of the corpus cavernosum was proposed as
the underlying cause of impotence and erectile dysfunction [18].
NO and cyclic GMP mediate the relaxation of the corpus
cavernosum in response to stimulation by nonadrenergic, non-
cholinergic neurons [18,19]. This seminal ﬁnding paved the way
for clinical treatment of erectile dysfunction with the drug,
sildenaﬁl (Viagra) that increase the steady-state levels of cyclic
GMP in the corpus cavernosum vessels (Fig. 8). The use of this
drug in patients who are taking organic nitrates (e.g., nitrogly-
cerin) for angina may result in serious drug interactions causing
hypotension and arrhythmias.
Peroxynitrite (the ugly side of O2
– or the bad side of NO?)
Peroxynitrite
The existence of the species peroxynitrite (ONOO) has been
demonstrated many years ago. Peroxynitrite anion is in equilibrium
with the corresponding peroxynitrous acid (ONOOH). The pKa of this
equilibrium is 6.8. Thus, under physiological conditions (pH¼7.4),
peroxynitrite exists mostly in the anionic form (80%) with about 20%
in the protonated form. The anionic form, ONOO , also reacts with
the carbon dioxide molecule that is typically present in millimolar
levels in cells. This reaction forms a very reactive adduct, nitrosoper-
oxycarbonate (ONOOCO2
) [20]. Both ONOO and ONOOCO2
 decays
rapidly at physiological pHs forming other radicals (OH, CO3–) that
are more potent and oxidizing in nature. Peroxynitrite oxidizes
protein thiols forming disulﬁde, nitrates tyrosyl groups in proteins
forming nitrated proteins. One of the consequences of nitratingtyrosyl groups in protein is either a loss or gain of function in the
activity (e.g., manganese superoxide dismutase; MnSOD). Nitration
can interfere with signal transduction mechanism. Potentially, nitra-
tion decreases the pKa of the –OH group of the tyrosine from about
10 down to 7.5. As a result, the –OH group is ionized to –O . This
shift in the ionization of the –OH group present in the tyrosine group
could impede phosphorylation and signaling mechanism. Peroxyni-
trite oxidizes unsaturated fatty acids in biological membranes to form
nitrated fatty acids that showmultiple and potent biological activities
[21]. Nitrated derivatives of oleic, linolenic, and arachidonic acids
were detected and characterized in human body ﬂuids [22]. The
reaction between peroxynitrite and DNA leads to multiple oxidized
products from purine and pyrimidine bases. Some of the biomarkers
of oxidative DNA damage (e.g., 8-hydroxy-2-deoxyguanosine (8-
OHdG) and 8-nitroguanine) are formed from the reaction between
peroxynitrite and DNA [23]. From the above, it is clear that formation
of this species in cells would lead to cytotoxicity.
How is peroxynitrite formed in cells? Is it a viable intracellular
reaction? It was shown that NO and O2– reacts at a nearly diffusion-
controlled rate to form the peroxynitrite [4]. This is signiﬁcant
because the higher the value of the rate constant, the greater is the
likelihood of the two species reacting to form the product. Thus, when
these two species are formed in cells, despite the presence of radical
scavengers and antioxidant enzymes, they will react because of the
higher rate constant. This was ﬁrst demonstrated in endothelial-
derived relaxing factor (EDRF) measurements. Addition of SOD
(enzyme that removes O2
– by catalyzing its dismutation reaction to
H2O2) enhanced the relaxing mechanism by increasing the levels of
NO [24]. This reaction is also critical to the process of vasoconstric-
tion and controlling the ratio of NO and O2– in hypertension.
NOþO 22 -ONOO k46:7 109 M21 s21
What are the consequences of this reaction? Potentially, there
are two consequences and both of which are bad. The NO/O2–
reaction forms a more cytotoxic species. Second, it removes NO
required for normal vasodilation.The enzymatic sources of NO and ROS, and how they can be
controlled
Enzymatic synthesis of NO
Studies showed that NO is produced from metabolism of the
amino acid, L-arginine. The enzyme(s) catalyzing this metabolic
pathway are known as nitric oxide synthases (NO synthases, or
NOS). NOS converts L-arginine to L-citrulline and NO via a
5-electron oxidation of one of the guanidine nitrogens of L-
arginine (Fig. 9). [25]. In the ﬁrst two-electron oxidation step,
N-hydroxy-L-arginine is formed as an enzyme-bound intermedi-
ate. In the second three-electron oxidation step, NO is formed
along with L-citrulline. The oxygen atom incorporated into NO
and L-citrulline originates from distinct molecules of oxygen
during the catalytic turnover to generate NO.
NADPH O
NADPH
2
e
NADP
oxidase
-
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Fig. 10. (A) Generation of reactive oxygen species from NADPH oxidases. (B) NOS structure and function. [Modiﬁed from: Streeter, J., et al. Cardiovascular Therapy; January
26 2012. http://dx.doi.org/10.1111/j.1755-5922.2011.00310.x. (Epub ahead of print)].
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lyzed oxidation of L-arginine to NO) also requires additional
co-factors, calmodulin, calcium, and tetrahydrobiopterin (BH4).
Inhibitors of NO biosynthesis
N-substituted analogs of L-arginine that inhibit the biosynthesis
of NO from L-arginine by all three NOS isoforms. These include
N-methyl, N-nitro, and N-amino L-arginine (L-NAME, L-NMMA).
Compounds, like 1400-W, inhibit only the iNOS isoform and not
others. Similarly, there are nNOS-speciﬁc inhibitors as well. These
agents are competitive inhibitors of the enzyme [26].
As mentioned earlier, BH4 is a key co-factor involved in the
biosynthesis of NO. Deﬁciency in intracellular BH4 levels caused by
decreased biosynthesis of BH4 has been shown to inhibit
NO
production. Thus, agents that modify BH4 synthesis and metabolism
such as sepiapterin will affect endogenous NO levels in cells and
tissues.
There are three isoforms of NOS that have been characterized,
puriﬁed, and cloned in chronological order: neuronal nitric oxide
synthase (nNOS) or NOS-1, inducible nitric oxide synthase (iNOS)
or NOS-2, and endothelial nitric oxide synthase (eNOS) or NOS-3.
The three isoforms are encoded by three different genes on
different chromosomes and share nearly 50–60% homology with
each other and with the cytochrome P-450 enzymes.
NOS isoforms located in different cellular compartments generate
NO for different reasons: nNOS in neurons makes NO for commu-
nication between nerve cells; iNOS in macrophages and smooth-
muscle cells makes NO in large quantities of NO as part of its killing
mechanism in response to lipopolysaccharide, cytokines, and gluco-
corticoids. Of course, if this form gets out of control, as occurs in septic
shock and inﬂammatory disorders, severe consequences (death)
follow; eNOS found in endothelium, brain, and heart makes NO to
relax blood vessels and maintain normal blood pressure.
Superoxide and hydrogen peroxide generation from NADPH oxidases
There are several enzymatic sources of superoxide, H2O2, and
oxidants derived there from. Xanthine/xanthine oxidase reduces
oxygen through a one-electron as well as a two-electron reduc-
tion mechanism, forming superoxide or H2O2 as a primary
intermediate. During this process, xanthine is converted to uric
acid. Allopurinol and oxypurinol inhibit formation of superoxideand H2O2 from xanthine oxidase. This enzyme is thought to play a
major role in ischemia/reperfusion injury [27].
Other enzymes that have been proposed to generate reactive
oxygen species are cytochrome P-450, cyclooxygenase, lipoxy-
genase, and mitochondria. However, these enzymes are not
typical ROS generating systems, and their major property is not
to generate O2
– and H2O2 as primary reactive species during their
catalytic activity. For example, lipoxygenase oxidizes linoleic acid
to generate biologically active lipid-derived products (HETEs) and
cyclooxygenase forms prostaglandins from arachidonic acid. The
primary function of mitochondria is to generate ATP. However,
aberrant functioning of these systems in diseases or environ-
mental toxicity generates ROS as a byproduct.
In contrast, NADPH oxidases (NOX) are a family of enzymes
that generate ROS (either O2
– or H2O2) as the primary species
during the catalytic metabolism of oxygen (Fig. 10). As indicated
elsewhere, the phagocytic NOX use ROS to kill bacteria. In most
inﬂammatory diseases and infections, enhanced ROS formation
occurs predominantly from NOX activation.
The NADPH oxidase is not a single enzyme, but it is a multi-
enzyme complex. Several isoforms of NOX are expressed in mam-
malian cells. NADPH is the electron donor for all NOX isoforms
(NOX1–5). Each of these isoforms contains a core catalytic subunit
(NOX) and several regulatory subunits that are located in the
cytosolic and membranous compartments (Fig. 10B). The various
components are assembled at the plasma membrane in functionally
active NADPH oxidase (or during activation) that transfers electrons
from NADPH to oxygen producing O2
– or H2O2. Some NOXs form
O2
– and others form H2O2. But their only known function is to
generate ROS. Because of their role in inﬂammation, infection, and
immune responses in various diseases, major pharmaceutical com-
panies are actively involved in drug discovery targeting the different
NOX isoforms.
Inhibition and interception of ROS and RNS
Aerobic organisms defend themselves against reactive oxygen
and nitrogen species through enzymatic and non-enzymatic detox-
ication mechanisms. The enzymatic detoxiﬁcation mechanisms
involve antioxidant enzymes (superoxide dismutases, catalases,
and peroxidases), small molecular-weight antioxidants (Vitamin E,
Vitamin C, glutathione, ubiquinone, beta-carotene, etc.), and adap-
tive mechanism leading to antioxidant gene expression.
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(SODs): copper, zinc, SOD (cytosolic), manganese SOD (mitochon-
dria), and EC-SOD (extracellular). SOD catalytically enhances the
normal dismutation of superoxide (O2
–þO2–þ2Hþ-H2O2þO2).
The rate constant for the normal dismutation is¼105 M–1 s–1. In
the presence of catalytic amount of SOD, the rate constant is
increased to 109 M–1 s–1. In other words, the rate of this reaction
is enhanced by 104-fold. The reaction mechanism of SOD
(Enzyme-Cu2þ) is shown in Scheme 1.
Superoxide reduces Cu2þ forming Cuþþ and O2, and another
superoxide molecule oxidizes Cuþþ back to Cu2þ , forming hydro-
gen peroxide. SOD is normally present at low micromolar con-
centrations in cells. This makes SOD-catalyzed dismutation of
superoxide very feasible. By decreasing the intracellular steadyScheme 1.
Scheme 2.
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Fig. 12. Structures of wellstate levels of s uperoxide, SOD could successfully inhibit the
reaction between O2
– and NO and the formation of a potent
oxidant, ONOO. In addition, SOD could prevent the release of
iron ions from the iron–sulfur cluster enzymes, as superoxide is
known to rapidly react with the iron–sulfur centers and release
iron. Thus, SOD can also indirectly prevent the formation of
hydroxyl radical from the Fenton reaction.
However, as shown earlier, SOD does not prevent the forma-
tion of H2O2. In some cases, SOD actually enhances H2O2 forma-
tion in cells. In contrast to O2
–, H2O2 is more stable and could
freely diffuse to other compartments in cells. H2O2 is detoxiﬁed to
water by catalases and peroxidases. The reaction between cata-
lase (CAT) and H2O2 is shown in Scheme 2.
As shown, CAT reduces H2O2 to O2 and H2O. CAT is more
important when H2O2 levels are low. At higher concentrations of
H2O2, glutathione peroxidase enzyme (GPx) that is dependent on
reduced glutathione is responsible for detoxifying H2O2. During
this process, reduced glutathione (GSH) is oxidized to oxidized
glutathione disulﬁde (GSSG) which is then reduced back to GSH
by glutathione reductase using NADPH as a co-factor. The GPx
enzyme is also responsible for detoxifying other lipid peroxides
(LOOH) to the corresponding alcohol (LOH). The dynamics of the
whole antioxidant enzyme machinery is shown in Fig. 11.
Phospholipid hydroperoxide-dependent glutathione peroxidase
(PHGPx) detoxiﬁes phospholipid hydroperoxides in the same way
as GPx detoxiﬁes lipid hydroperoxides. Phospholipid hydroperoxides
that are located inside the membrane are not accessible to GPx.
However, GPx and PLA2 (phospholipase A2, an enzyme that hydro-
lyzes phospholipid hydroperoxides and releases lipid hydroperoxides)
are capable of detoxifying phospholipid hydroperoxides [28].
In addition to these enzymes, other mechanisms (peroxire-
doxin, thioredoxin) are involved in detoxifying intracellular hydro-
peroxides. Peroxiredoxins are ubiquitous class of antioxidant or
signaling proteins present at high concentrations (50–100 mM) in
cytoplasm and mitochondria. Peroxiredoxins react very rapidly
with H2O2 (k410
7 M–1 s–1) [29].CAT, catalase; GPx, 
glutathione peroxidase;
GR, glutathione 
CAT
½ O2+ H2O
reductase GSH reduced
glutathione; GSSG, 
R
oxidized glutathione;
PPP, pentose phosphate 
pathway;PR,
H2O peroxyredoxins; SOD, 
superoxide dismutase
ion of hydrogen peroxide.
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(copper and iron ions), aldehydes (MDA, 4-HNE) are formed as
byproducts of lipid hydroperoxide decomposition. These products,
when formed in excess, are biologically toxic as they will react
with proteins and macromolecules and cause inactivation. How-
ever, as will be shown later in this section, these electrophiles are
also able to induce antioxidant gene expression through activation
of the Keap1–Nrf2 system. Aldehydes (MDA or 4-HNE) are detox-
iﬁed by glutathione transferases which enables the conjugation of
thiols (glutathione) forming the aldehyde–GSH conjugate [30].
Note: This type of detoxiﬁcation reaction is very similar to the
removal of N-acetylquinone amine by N-acetylcysteine.
The concentration of metal ions such as iron is regulated
by ferritin and ceruloplasmin. Ferritin has numerous binding sites
for iron. The cell will overexpress ferritin in order to protect itself
from iron toxicity. Ferritin can indirectly inhibit formation of hydroxyl
radicals and other toxic aldehydes.
Intracellular iron is tightly controlled by a very sophisticated
iron-signaling mechanism. Under conditions of iron deﬁciency,
cells acquire iron via increased synthesis of transferrin receptor
that facilitates the uptake of iron-transferrin. During iron over-
load, TfR receptor synthesis is decreased and ferritin receptor
synthesis is increased.
In addition to enzymatic mechanisms of protection again
reactive oxygen species, there exist non-enzymatic small mole-
cular weight antioxidants: ascorbic acid (also vitamin C), alpha-
tocopherol (also vitamin E), reduced glutathione (present in
millimolar levels in cells), beta-carotene (Fig. 12).
Antioxidants act in different ways. It is important to take into
account the localization of antioxidants. These small molecular
weight antioxidants are not able to deal with H2O2 as they will
only react really slowly (if at all) with H2O2. However, vitamin E
which is lipophilic (located in the biological membrane) will react
with the lipid peroxyl radical produced during lipid peroxidation
process. The vitamin E radical reacts with the lipid peroxyl radical
and this reaction is a chain termination event. As a result, vitamin E
is a very effective chain-breaking antioxidant that can stop lipid
peroxidation in its tracks (so to speak). In contrast to vitamin E,
vitamin C is water-soluble and will react rapidly with a variety of
reactive oxygen species including superoxide and hydroxyl radical
forming the ascorbate radical, which reacts with another ascorbate
radical forming dehydroascorbate and ascobate. Ascorbate is,
therefore, termed as a cytosolic antioxidant.
Although ascorbate is present in the cytosol, it can recycle the
membrane-associated vitamin E radical back to vitamin E,LOO• VitE
Cell 
membrane
LOOH VitE radical
Ascorbate ASC
radical
Intracellular
Dehydro-
ascorbateGSSG
GSH
NADPH
NADP+
Fig. 13. The cross-talk between lipophilic and hydrophilic antioxidants.thereby increasing the total antioxidant potential. The Pentose
Phosphate Pathway keeps the ascorbate and vitamin E in the
reduced form through the intracellular reductant, GSH (Fig. 13).Oxidative stress, oxidative damage, and adaptation to
oxidative stress
What is oxidative stress (OS)?
This is one of the most frequently used terms in free radical
biology. OS refers to the imbalance between the prooxidant and
antioxidant levels in favor of prooxidants in cells and tissues. This
scenario leads to modiﬁcation of lipids, proteins, and DNA. Such
modiﬁcations or damage to these molecules are called oxidative
damage. Prooxidant is a species that causes or promotes oxidation.
Antioxidant is a molecule inhibits formation of prooxidants and
inhibits oxidation. Antioxidants are usually present at a low
concentration and yet inhibit oxidation of an oxidizable substrate.
Oxidative stress can result from diminished antioxidant levels
or antioxidant enzymes or defects in antioxidant machinery
expressing the antioxidant gene. Depletions of dietary antioxidants
(e.g., vitamins E, C, and D, ﬂavonoids and carotenoids) and micro-
nutrients (e.g., iron, copper, zinc, selenium) that are needed for
proper functioning of antioxidant enzymes (catalase, copper, zinc
SOD, or glutathione peroxidase) results in the accumulation of
prooxidants (free radicals or reactive oxygen species), leading to
oxidative stress. Several diseases (e.g., kwashiorkor disease) asso-
ciated with protein deﬁciency in children are caused by low levels
of glutathione and enhanced iron (iron overload). Administering
antioxidant therapy might be beneﬁcial under these conditions.
Oxidative stress can also result from increased production of
reactive oxygen species from exposure to toxins (e.g., paraquat or
cigarette smoke) and activation of endogenous enzymes (e.g.,
NADPH oxidases) in chronic inﬂammatory conditions.
Oxidative damage
One of the consequences of oxidative stress is cell injury
caused by oxidative damage. Targets of oxidative damage are
DNA, lipid, and protein. Both purine (adenine and guanine) and
pyrimidine (cytosine and thymine) react with hydroxyl radical to
form speciﬁc products [2].
However, not all reactive species (O2
– and H2O2 or NO) react
with DNA bases or with the deoxyribose. NO and O2– together
reacts with DNA bases. Hydroxy radical adds to the C-8 position of
guanine and forms 8–hydroxyguanine (8-OH-guanine). Other DNA
bases are also oxidized similarly by hydroxyl radical. A major
consequence of oxidative damage to DNA bases is mutation caused
by AT2GC transition and by GC2TA transversion. These muta-
tions, if unrepaired, can lead to changes in protein gene expression.
Protein modiﬁcations caused by ROS/RNS include formation of
carbonyls, dityrosine and nitrated and chlorinated tyrosines. Nitrated,
chlorinated, and brominated tyrosines have been detected in high
levels in diseased tissues in patients with inﬂammatory diseases.
Lipids (containing conjugated double bonds) undergo perox-
idation in the presence of ROS/RNS and oxygen. Arachidonic acid
with four double bonds is more easily oxidized than linolenic acid
(three double bonds) and linoleic acid (two double bonds). Oleic
acid with a single double bond is not peroxidized. During this
chain oxidation reaction, several molecules of lipid (LH) are
oxidized. In the initiation process, oxidants (hydroxyl radical)
abstract the allylic hydrogen forming the carbon-centered lipid
radical. This radical undergoes a molecular rearrangement to
produce a more stable carbon-centered radical (L) which rapidly
reacts with oxygen to form a lipid peroxy radical (LOO). In the
↑ ROS
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cytoplasm Keap1
Antioxidant
gene ↑
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oxygenase, γ-GTP) 
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Fig. 15. Activation of Keap1–Nrf2–ARE pathway by ROS.
B. Kalyanaraman / Redox Biology 1 (2013) 244–257 253propagation phase, the LOO abstracts a hydrogen from another
lipid molecule generating a new L. (that continues the chain
reaction) and lipid hydroperoxide (LOOH). This process will go on
forever unless terminated by phenolic antioxidants (vitamin E or
BHT). In the termination reaction, vitamin E or BHT donates
a hydrogen atom to the LOO species and forms a corresponding
vitamin E or BHT radical that reacts with another LOO forming
non-radical products. These lipophilic phenolic antioxidants
are known as the chain-breaking antioxidants. The rancidity of
butter is due to the lipid peroxidation process, and the food
additive BHT effectively terminates lipid peroxidation and keeps
the butter fresh even when left outside at room temperature.
Atherosclerosis, the formation of plaques in the arteries with
time, is initiated from lipid peroxidation (the rancidity of the body
fat) of low-density lipoprotein (LDL) (Fig. 14). The LOOH molecule
is unstable and one usually detects isoprostanes or 4-HNE as
speciﬁc end products of peroxidized lipid.Adaptive response in cells exposed to mild to moderate oxidative
stress.
As discussed in the previous section, cells cope with oxidants (O2
–,
H2O2, LOOH) through several detoxiﬁcation mechanisms afforded by
endogenous antioxidant enzymes and small molecular-weight anti-
oxidants. Paradoxically, this process (continued exposure to a mild
dose of oxidants) actually results in increased syntheses of antiox-
idant enzymes. This is an intrinsic mechanism by which cells restore
the oxidant/antioxidant balance. How does this happen?What makesH H
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Fig. 14. Lipid peroxidation: oxidation of unsaturated fatty acids to lipid
hydroperoxide.these cells stronger? What is the signal transduction mechanism that
is responsible for this paradoxical effect?
The three cellular components involved in this signaling mechan-
ism at the transcriptional level are: Kelch-like ECH-associated protein
1 (Keap1), nuclear factor erythroid 2-related factor 2 (Nrf2), and
antioxidant response elements (ARE). Research indicates that the
Keap1-Nrf2-ARE signaling pathway is responsible for ‘‘turning on’’ the
adaptive response against oxidant stress. The binding of Nrf2 to the
DNA sequences present in ARE induce transcription of cytoprotective,
antioxidant genes including SOD, GPx, CAT, gamma-GCS, GST. In
addition, several other cytoprotective genes (heme oxygenase, NQO-
1) are induced. As shown in Fig. 15, under normal conditions (reduced
intracellular conditions), Nrf2 is stabilized through binding to Keap-1
in the cytoplasm. During enhanced ROS formation or exposure to
electrophilic metabolites, the cysteine residues in Keap-1 are mod-
iﬁed or oxidized causing the dissociation of Nrf2 and translocation to
the nucleus and binding to the ARE. Depending upon the binding site
present on the promoter region, the different antioxidant genes are
induced.Dietary antioxidants and exercise
Dietary antioxidants
Induction of the signaling pathway (Keap1/Nrf2/ARE) leading to
overexpression of major inﬂammatory enzymes has been implicated
in a variety of diseases as an adaptive mechanism to cope with
oxidative stress. ARE inducers or activators are generally electrophilic.
Electrophilic compounds typically contain a double bond conjugated
to an electron-withdrawing carbonyl group. These compounds react
readily with the sulfhydryl group present in the cysteinyl residues
(this reaction is known as the Michael addition reaction) (Fig. 16).
Several food components or phytochemicals (e.g., curcumin, cinna-
mon derivatives, diallyl sulﬁde, isothiocyanate) are known to activate
the Keap1/Nrf2/ARE pathway and induce numerous cytoprotective
genes involved in Phase 11 response. This includes induction of
antioxidant and repair enzymes.
Curcumin, or turmeric, a major component of Indian curry, has
two phenolic functional groups and a beta-diketo group. This
compound reacts readily with cysteine sulfhydryl group and
activate Keap1-Nrf2-ARE pathway. The chemopreventive effect of
green tea and broccoli is attributed to activation of Nrf2 (Fig. 17).
All substances are poisons. ‘‘The right dose differentiates a poison
from a remedy’’ (Paracelsus, 1493–1541). Are antioxidants always
good? In a recent study published in the Proceedings of the National
Academy of Sciences, researchers reported that antioxidants indeed
prevented the health-promoting effects of physical exercise in
humans. It is known that exercise promotes longevity, promotes
expression of antioxidant defense (sod1/2, GPx1, catalase)
and decreases type 2 diabetes mellitus and insulin resistance
Fig. 16. The proposed reaction mechanism of Michael addition reactions between Michael acceptors and cysteine sulfhydryl groups in Keap1. [From: Magesh, S., et al.
Small molecule modulators of Keap1–Nrf2–ARE pathway as potential preventive and therapeutic agents. Medicinal Research Reviews 32:687–726; 2012.].
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Fig. 17. Botanical phenolics and brain health. [From: Mattson, M. P.; Cheng. A.
Trends in Neurosciences 29:632–639; 2006.]
NAD(P)H F DOX._ O2
FH.
NAD(P)+ FH2 DOX H 2O 2O 2
.-
Fe-S clusters
H 2O 2
•OH
Fe 2+Fe (IV) O
DOX • Fe
mitochondrial
lipid peroxidation 
mitochondrial
protein oxidation 
mitochondrial
DNA damage
sarcolemmal, mitochondrial and sarcoplasmic reticular changes 
Contractile Impairment 
Fig. 18. Free radical hypothesis of cardiotoxicity.
B. Kalyanaraman / Redox Biology 1 (2013) 244–257254(mitohormesis) [31]. However, exercise also enhances mitochondrial
formation of reactive oxygen species.
Daily ingestion of vitamin C and E totally abrogated the health-
promoting effects of exercise, as physical exercise failed to
promote insulin insensitivity and antioxidant gene expression
by blocking exercise-dependent ROS formation in individuals
supplemented with antioxidants. Clearly a little bit of exercise-
induced oxidative stress is good to enhance the endogenous
antioxidant defense that is longer lasting. I am reminded of the
quote ‘‘everything in moderation, including moderation’’.
Toxic side effects of commonly used drugs
Adverse side effects of drugs: role of reactive oxygen/nitrogen species.
The success of chemotherapy (treating cancer with drugs) is
dependent upon the therapeutic window—the difference in cytotoxi-
city between the normal cells and the tumor cells. Several chemother-
apeutic drugs (doxorubicin, cis-platin, bleomycin) that are being
widely used in treating various cancers are beset with adverse side
effects with prolonged use or even long after the cessation of
chemotherapy in patients who are free of tumors. Understanding
the molecular mechanism of adverse side effects in target organs of
toxicity in these patients will greatly enhance the quality of life in
cancer survivors.
Doxorubicin or Adriamycin
Doxorubicin (DOX) or Adriamycin, belongs to a group of antic-
ancer drugs called anthracyclines. The chemical structure of all the
anthracyclines is very similar and consists of a tetracycline ring
(marked A–D).
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CD B AAs shown in the structure of doxorubicin (DOX), there are four
different functionally important regions that are color-coded: Qui-
none (dark blue), hydroquinone (light blue), alicyclic side chain
(green), and the sugar group (red). The prototypical anthracycline,
DOX, is currently being used, alone and in combination therapy, to
treat a wide variety of cancers, including breast cancer, Hodgkin’s
disease, leukemia, and testicular cancer.
The clinical use of DOX in adult breast cancer patients,
however, is associated with a dose-dependent increase in cardi-
otoxicity (arrhythmias, ventricular dysfunction, and cardiomyo-
pathy or congestive heart failure) that is observed in patients
decades after cessation of DOX chemotherapy. This problem also
manifests in pediatric cancer patients. Children treated with DOX
for acute lymphoblastic leukemia (ALL) developed heart problems
years after completion of chemotherapy [32]. Estimates indicate
that children who undergo DOX chemotherapy are nearly eight
times more susceptible to develop heart problems later in life.
Knowing the mechanism of injury to myocardial cells will lead to
cardioprotective drug treatment post-chemotherapy.
Existing literature implicates the involvement of free radicals and
reactive oxygen species in DOX cardiotoxicity. One-electron reduc-
tion of the quinone group in ring C of DOX results in the formation
of a DOX semiquinone radical that undergoes redox-cycling in the
presence of oxygen to form superoxide anion (Fig. 18). This is called
a futile redox-cycling process (the substrate, DOX, is not consumed
during the reaction). This reduction is catalyzed by several NADH-or
NADPH-dependent enzymes such as cytochrome P450, mitochon-
drial dehydrogenase, or xanthine dehydrogenase (FH). Interaction
between hydrogen peroxide and the redox-active iron that is
released from the reaction between superoxide and the mitochon-
drial iron–sulfur protein (aconitase) results in the generation of
hydroxyl radicals. DOX-induced generation of hydroxyl radicals are
capable of oxidizing lipids, proteins, and nucleic acid in mitochon-
dria, ultimately leading to lipid peroxidation, protein carbonyls, and
DNA damage. A schematic representation of oxidative events
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Modifying the conformation of the –OH group present in the sugar
moiety results in a less cardiotoxic form of DOX (epirubicin) that is
metabolized faster.
The target organ of DOX toxicity is the myocardium which is
mitochondria-rich. One of the reasons why heart muscle is increas-
ingly susceptible to oxidant-induced damage is due to the low levels
of antioxidant enzymes (catalase, glutathione peroxidase) that can
detoxify hydrogen peroxide and lipid peroxides. DOX also accumu-
lates into mitochondria. Under these conditions, the antioxidant
defenses can easily be overwhelmed, leading to oxidation of critical
proteins involved in ATP generation in mitochondria. Recent research
also suggests that DOX oxidative metabolism in mitochondria stimu-
lates iron signaling, resulting in a ‘‘vicious’’ cycle of oxidant formation.
Increased sensitivity of pediatric cancer patients to DOX-induced
cardiotoxicity might be due to decreased antioxidant enzymes in the
myocardium.
Several lines of research suggest that iron plays a major role in
DOX-induced cardiotoxicity. Iron chelators have been used clinically
to manage DOX toxicity in breast cancer patients. One of the
frequently used drugs is ICRF-187, or dexrazoxane. ICRF-187 is a
pro-drug but needs to be activated intracellularly to an active
metabolite that has the iron-chelating ability. In both preclinical
and clinical studies, pretreatment with dexrazoxane protects against
cardiomyopathy. This drug also mitigates cardiac injury (as mea-
sured by troponin T levels) in children with ALL in response to DOX
chemotherapy. Dexrazoxane does not compromise the efﬁcacy of
cancer treatment. This drug does not inhibit the DNA damage
mediated by topoisomerase 11 present in cancer cells. Results from
these studies indicate that DOX-induced myocardial injury may in
part be related to iron-mediated oxidative damage. Emerging
reports suggest that mitochondria-targeted antioxidants could effec-
tively attenuate DOX-induced mitochondrial damage.
Cisplatin
Cisplatin (cis-diaminedichloroplatinum 11) is widely used as a
ﬁrst line of chemotherapy for treating a broad
spectrum of tumors including testicular, cervical, and ovarian
tumors. The clinical utility is, however, hampered due to its dose-
dependent nephrotoxicity and ototoxicity (hearing loss due to
damage to auditory cells). These adverse effects result inCisplatin
Pro-inflammatory cytokines
NOXs, iNOS
_
O2 •NO
ONOO-
Nitration and oxidation Renal cell death
•
Fig. 19. Molecular mechanism of cisplatin-induced inﬂammation.treatment with a lower dosage or termination of treatment. The
primary cytotoxic effect is due its interaction and intercalation
into DNA, leading to inter- and intra-strand cross links, defective
DNA templates, impaired DNA repair, and inhibition of DNA
replication in rapidly dividing tumor cells. Studies suggest that
mitochondria are a major target of cisplatin. In addition to the
ﬁrst wave of oxidative damage, a secondary wave of reactive
oxygen species formation occurs from proinﬂammatory cytokines
from leukocyte inﬁltration induced by cisplatin and subsequent
activation of NADPH oxidase activity. Increased expression of
NOX enzymes responsible for sustained generation of O2
– and
ONOO was detected in the kidneys of cisplatin treated animals.
Fig. 19 summarizes the sustained generation of reactive oxygen
and nitrogen species in response to cisplatin-induced pro-inﬂam-
matory cytokines.Acetaminophen (or paracetamol, as known outside the US).
Acetaminophen is one of the most widely used analgesics
worldwide. While safe at therapeutic doses, overdose or too-
frequent high dose (supratherapeutic dose) leads to severe liver
injury and even death. Acetaminophen poisoning (intentional
overdose with therapeutic intent) results in nearly 500 deaths
each year (in the US). Studies have shown that a majority of the
drug is metabolized to nontoxic metabolites through conven-
tional phase 2 metabolic pathways. However, a minor component
(5%) of acetaminophen is metabolized by cytochrome P450
enzymes (CYP), especially CYP2E1 isoform, to the reactive, elec-
trophilic intermediate or electrophile, N-acetyl-p-benzoquinone
imine (NAPQI) [33]. NAPQI is very reactive and its toxicity in the
liver results from its covalent binding to proteins (with cysteines)
and nucleic acids. However, as long as sufﬁcient glutathione is
present in the liver, NAPQI is detoxiﬁed by glutathione (a strong
nucleophile) forming cysteine and mercapturic acid conjugates.
During this reaction, hepatic glutathione is depleted due to a
rapid reaction between NAPQI and –SH moiety of GSH. This
reaction is also catalyzed by glutathione transferase enzyme
(GST) forming an acetaminophen–cysteine conjugate. In the
absence of intracellular GSH or decreased GSH levels, NAPQI will
indiscriminately react with proteins (present in the endoplasmic
reticulum, the Ca2þ transport system, and/or mitochondria) and
contribute to hepatic cell death. Note that alcoholics are more
vulnerable to acetaminophen toxicity due to decreased GSH and
elevated CYPE1 activity.
The only effective therapy that is currently available for
acetaminophen toxicity is N-acetylcysteine therapy. N-
acetylcysteine is more readily absorbed into hepatic tissues than
cysteine. Once inside the cell, N-acetylcysteine is hydrolyzed to
cysteine, a limiting substrate that restores glutathione synthesis
and inhibits liver tissue injury [34]. In order to be therapeutically
effective, N-acetylcysteine should be administered to
acetaminophen-overdosed patients within 12–24 h following
ingestion.
The importance of oxidative stress in acetaminophen toxicity
remains controversial, although reports now indicate the activa-
tion of Kupffer cells and recruitment of neutrophils and mono-
cytes (innate immune response) during the later phase of drug
overdose. As a result of the inﬂammatory response, increased
formation of NO, O2–, and ONOO likely occurs during the later
phase. Overall, acetaminophen overdose produces severe liver
injury leading to cell necrosis via metabolic activation, glu-
tathione depletion, alkylation of proteins, mitochondrial dysfunc-
tion, and formation of reactive oxygen and nitrogen species.
Timely administration of N-acetylcysteine therapy protects
against hepatotoxicity.
Fig. 20. The role of angiotensin II and mechanical stress in the generation of
reactive oxygen species in the vessel wall in patients with hypertension. [Modiﬁed
from: Sowers, J. R. Hypertension, angiotensin II, and oxidative stress. New England
Journal of Medicine 346:1999–2001; 2002.].
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Inﬂammatory diseases, oxidative conditions, decreased NO
From the above discussion, it is evident that NO plays a vital
role in the maintenance of normal endothelial function. Under
pathophysiological conditions promoting formation of reactive
oxygen species, this situation dramatically changes, leading to a
decreased NO bioavailability. There are many examples in
cardiovascular, neurodegenerative, and other chronic inﬂamma-
tory diseases in which NO levels are critically compromised.
What is the basic chemical mechanism that is responsible for this
acute shortage of NO in the vasculature? One of the radical
culprits that cause this problem is superoxide, as demonstrated in
renovascular hypertension research (Fig. 20). In this disorder, the
reduced arterial perfusion to one or both kidneys elevates
circulating levels of angiotensin II due to increased production
of renin. Angiotensin II activates membrane-bound NADPH
oxidase that stimulates O2
– formation in the vessel wall in
patients with hypertension [34].
Because of the diffusion-controlled reaction rate between NO and
O2
–, it is very likely that this reaction contributes to NO depletion,
thereby impairing endothelium-dependent vasodilation. Further-
more, an even more potent oxidant, peroxynitrite (ONOO), is
formed in this process. Peroxynitrite may further augment vascular
injury by reacting with BH4, an essential co-factor involved in
NO
biosynthesis by endothelial NOS and depleting BH4 in the vessel wall.
This leads to a vicious cycle scenario in which NO biosynthesis is
ultimately inhibited by angiotensin-mediated O2
–. Note that pub-
lished data suggest that this condition is corrected by renal angio-
plasty, leading to downregulation of the renin–angiotensin system
(and inhibition of production of angiotensin II) or by administering
ascorbic acid. Ascorbic acid will react with both O2
– and ONOO but
not with NO. Consequently, the bioavailability of NO is increased in
the vessel wall in these patients.
The development of drugs that activate endogenous antiox-
idant enzymes for treating inﬂammatory diseases [chronic kidneydisease (CKD) associated with type 2 diabetes] is currently
underway. It has been shown that bardoxolone methyl, an orally
active antioxidant drug, is able to decrease inﬂammation and
oxidative stress associated with CKD. The mechanism of action
appears to be related to activation of NrF2. Unfortunately, due to
unexpected toxicity, clinical trials of this drug were suspended.
Despite the setback, mitigating oxidative stress in inﬂammatory
diseases may become a crucial factor for successful drug therapy.
The question, ‘‘Doctor, can you tell me more about oxidants,
antioxidants and free radicals,’’ is more realistic now than ever
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